Discover an illuminating webinar on proteolysis targeting chimeras (PROTACs), a game-changing technology that is revolutionizing drug discovery and beyond. These catalytic entities are transforming biomedical research, drug discovery and agrochemical industries by selectively degrading specific proteins, including traditionally “undruggable” targets.
In this webinar, the expert speakers will cover key aspects shaping the future of PROTACs:
- Decoding PROTACs: Explore the unique mechanism behind PROTACs and what makes them unique as targeted protein degraders
- Biomedical Breakthroughs: Uncover how PROTACs are paving the way for new treatments for a spectrum of diseases, from cancer to neurodegenerative disorders
- Precision Redefined: Learn how PROTACs offer targeted therapies with reduced side effects, promising a new era in personalized medicine
- Crop Protection Reinvented: Discuss the potential of PROTACs in enhancing crop protection and sustainable agriculture practices
Register for this webinar today to understand the versatile and potent capabilities of PROTACs and their potential impact in biomedical research, drug discovery and agrochemicals.
Speakers
Shanavas Alikunju, PhD, SVP & Head, Discovery Biology Solutions, Aragen Life Sciences
Shanavas Alikunju comes with over two decades of cross-functional experience and has led several NCE drug discovery & differentiated formulation projects in oncology, cardiovascular, metabolic disorder, pain, inflammation, neurology and dermatology therapeutic areas.
Prior to joining Aragen, he has worked for Dr. Reddy Labs. He has completed his Postdoctoral degree from Baylor College of Medicine, Houston, and University of Texas Medical School at Houston (USA).
Message Presenter
Indrani Sarkar, AVP, Assay Development and Screening, Discovery Biology Solutions, Aragen Life Sciences
Indrani Sarkar comes with over 15 years of multidisciplinary research experience post-PhD and has contributed to the contract research, biotechnology and pharmaceutical sectors.
Sarkar brings experience from previous roles at Glenmark Pharmaceuticals, Life Technologies and Syngene International Limited. Indrani Sarkar holds a PhD with a robust skill set that includes life sciences, cell culture, molecular biology, biotechnology and biochemistry.
Message PresenterWho Should Attend?
This webinar will appeal to:
- Biochemists/Molecular Biologists/Cell Biologists
- Pharmacologists/Medicinal Chemists
- Structural Biologists
- Pharmaceutical/Biotech Scientists
- Medicinal Chemists/Synthetic Chemists
- Clinical Researchers
- R&D Managers/Project Leads
What You Will Learn
Attendees will learn about how PROTACs:
- Can transform drug discovery by selectively degrading specific proteins
- Offer precision in targeted therapies with reduced side effects
- Promise innovations in crop protection and sustainable agriculture practices
Xtalks Partner
Aragen Life Sciences
Aragen Life Sciences is a leading R&D and manufacturing solutions provider for the life sciences industries worldwide. It offers end-to-end integrated or standalone solutions for small and large molecules. Established in 2001, the Company operates through a network of sites located globally with a team of 3700+ scientists and 450+ PhDs. Its expertise and experience have enabled over 400 customers to advance their research programs from discovery through commercialization. Aragen’s innovative mindset, infrastructure, flexible business models have enabled us to serve large pharma, biotech, agrochemical, animal health and performance chemical industries globally. Visit www.aragen.com for more details
You Must Login To Register for this Free Webinar
Already have an account? LOGIN HERE. If you don’t have an account you need to create a free account.
Create Account